Department of Oncology, Gray Institute of Radiation Oncology and Biology, University of Oxford, Oxford, UK.
Prostate. 2013 Sep;73(13):1427-40. doi: 10.1002/pros.22690. Epub 2013 Jun 14.
Matrix metalloproteinase 9 (MMP9) has been implicated in extracellular matrix (ECM) remodelling, angiogenesis and inflammation. However, the targets for proteolysis that lead to these physiological consequences are often undefined as is the regulation of MMP9 itself. Therefore, identification of both the potential direct and indirect targets of MMP9 is critical for further understanding the effects of its proteolytic cascades.
To study these cascades on a wider scale, transgenic mouse "knock-out" models and ultra-high performance liquid chromatography mass spectroscopy (UPLC-MS(E) ) were used to elucidate the MMP9 targets, inhibitors, and interactors found in mouse seminal vesicle fluid (SVF).
Proteomics analysis of SVF from wild type, mmp9-/- or pn1-/- mice detected differences in serine protease inhibitors (serpins), reproductive proteins, developmental regulators, and cancer proto-oncogenes, including Renin 1/2. Protease nexin 1 (PN1), an ECM-based inhibitor of urokinase, was elevated in the SVF of mmp9-/- mice. We observed that MMP9-mediated N-terminal cleavage of PN1 reduces this serpin's functional activity. Our data also suggest a feedback loop in which inhibition of PN1 is a critical step in permitting greater activity of MMP9.
This study extends the degradome of MMP9 and examines components relevant to seminal fluid physiology. PN1 is proposed to be a novel inhibitor of MMP9 activity and a block to collagen cleavage, a frequent antecedent to cancer cell invasion. The interaction of MMP9 with PN1 and other serpins may lead to a better understanding of seminal vesicle function and possible impacts on fertility, as well as provide novel therapeutic targets.
基质金属蛋白酶 9(MMP9)参与细胞外基质(ECM)重塑、血管生成和炎症。然而,导致这些生理后果的蛋白水解靶标通常不明确,MMP9 本身的调节也是如此。因此,鉴定 MMP9 的潜在直接和间接靶标对于进一步了解其蛋白水解级联反应的影响至关重要。
为了更广泛地研究这些级联反应,使用转基因小鼠“敲除”模型和超高效液相色谱-质谱(UPLC-MS(E))来阐明在小鼠精囊液(SVF)中发现的 MMP9 靶标、抑制剂和相互作用物。
对野生型、mmp9-/-或 pn1-/-小鼠 SVF 的蛋白质组学分析检测到丝氨酸蛋白酶抑制剂(丝氨酸蛋白酶抑制剂)、生殖蛋白、发育调节剂和癌症原癌基因的差异,包括肾素 1/2。基质金属蛋白酶 9(MMP9)介导的蛋白酶抑制剂 1(PN1)的 N 端切割增加了 mmp9-/-小鼠的 SVF。我们观察到 MMP9 介导的 PN1 中 N 端切割降低了该丝氨酸蛋白酶抑制剂的功能活性。我们的数据还表明存在反馈回路,其中 PN1 的抑制是允许 MMP9 活性增加的关键步骤。
本研究扩展了 MMP9 的降解组,并研究了与精液生理学相关的成分。PN1 被提议为 MMP9 活性的新型抑制剂,也是阻止胶原蛋白裂解的抑制剂,胶原蛋白裂解是癌细胞侵袭的常见前兆。MMP9 与 PN1 和其他丝氨酸蛋白酶抑制剂的相互作用可能有助于更好地了解精囊功能以及对生育能力的可能影响,并提供新的治疗靶标。